Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Current Assets

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Current Assets ₹11,300 Cr₹9,295 Cr₹7,428 Cr₹8,424 Cr₹8,282 Cr

What is the latest Total Current Assets ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Current Assets ratio of GLENMARK PHARMACEUTICALS is ₹11,300 Cr based on Mar2026 Consolidated results.
Year Total Current Assets
Mar2026₹11,300 Cr
Mar2025₹9,295 Cr
Mar2024₹7,428 Cr
Mar2023₹8,424 Cr
Mar2022₹8,282 Cr

How is Total Current Assets of GLENMARK PHARMACEUTICALS Trending?

Years Total Current Assets % Change
Mar2026 ₹11,300 Cr
21.56
Mar2025 ₹9,295 Cr
25.14
Mar2024 ₹7,428 Cr
-11.82
Mar2023 ₹8,424 Cr
1.71
Mar2022 ₹8,282 Cr -

Compare Total Current Assets of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹69,308.3 Cr 6.5% 8.6% 25.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,994.0 Cr -0% -4.5% 15.9% Stock Analytics
DIVIS LABORATORIES ₹240,249.0 Cr 5.9% 16.1% 49.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,135.0 Cr 3% 3% 34% Stock Analytics
CIPLA ₹114,708.0 Cr -0.4% -3.6% -11.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.9 Cr NA 2.8% -7.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

6.5%

8.6%

25.7%

SENSEX

-0.8%

0.2%

-6%


You may also like the below Video Courses